3 Essentials For A Fit-For-Purpose Compliance Strategy In Decentralized Pharma

By Penelope Przekop, MSQA , RQA P-GCP, and Valerie Przekop

Outsourcing and technology have morphed our industry into a new decentralized model. Now, each sponsor must carefully develop an ongoing compliance strategy considering its unique business model and its influence on the drug development journey. Strategies are needed to design quality management systems (QMSs) that can expand and pivot in tandem with corporate and clinical development.